Funding Details
- Awarder
- Inbox
- Date Award
- June 24, 2020
- Vertical
- Biopharmaceuticals
- Funding URL
- View Funding Page
Company Info
- Company Description
- AsclepiX Therapeutics Inc. is a biopharmaceutical company using computational biology to identify potent peptide regulators of vascular homeostasis that is disrupted in retinal and oncologic diseases. The novel clinical candidate peptides discovered by AsclepiX tap into these naturally existing self-regulating mechanisms, evolved over millions of years, that the body uses to maintain homeostasis and thus restore and maintain health.
- Market
- Retinal and oncologic diseases
- Coinvestors
- Perceptive Advisors, Rapha Capital Management
Links